Attenuated CSMD1 expression in HGG samples may modify the cytokine profile of glioma cells induced by TNF, thereby potentially aligning with the immunosuppressive phenotype in the glioma microenvironment. The gene discussed is CSMD1; the disease is central nervous system cancer.